Sexual dimorphism in schizophrenia: is there a need for gender-based protocols?

References

• Andreasen NC, Carpenter WT Jr. Diagnosis and classification of schizophrenia. Schizophr Bull.19(2), 199–214 (1993).
   PubMed Web of Science ®Google Scholar
• Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch. Gen. Psychiatry64(10), 1123–1131 (2007).
   PubMed Web of Science ®Google Scholar
• Leung A, Chue P. Sex differences in schizophrenia, a review of the literature. Acta Psychiatr. Scand. Suppl.401, 3–38 (2000).
   PubMedGoogle Scholar
• Abel KM, Drake R, Goldstein JM. Sex differences in schizophrenia. Int. Rev. Psychiatry22(5), 417–428 (2010).
   PubMed Web of Science ®Google Scholar
• Johnson J, Stewart DE. DSM-V: toward a gender sensitive approach to psychiatric diagnosis. Arch. Womens Ment. Health13(1), 17–19 (2010).
   PubMed Web of Science ®Google Scholar
• Seeman MV. Secondary effects of antipsychotics: women at greater risk than men. Schizophr. Bull.35(5), 937–948 (2009).
   PubMed Web of Science ®Google Scholar
• Lindamer LA, Lohr JB, Harris MJ, Jeste DV. Gender, estrogen, and schizophrenia. Psychopharmacol. Bull.33(2), 221–228 (1997).
   PubMedGoogle Scholar
• Hafner H. Gender differences in schizophrenia. Psychoneuroendocrinology28(Suppl. 2), 17–54 (2003).
   PubMed Web of Science ®Google Scholar
• Flor-Henry P. Schizophrenia: sex differences. Can. J. Psychiatry30(5), 319–322 (1985).
   PubMed Web of Science ®Google Scholar
• Tamminga CA. Gender and schizophrenia. J. Clin. Psychiatry58(Suppl. 15), 33–37 (1997).
   PubMedGoogle Scholar
• Ring N, Tantam D, Montague L et al. Gender differences in the incidence of definite schizophrenia and atypical psychosis – focus on negative symptoms of schizophrenia. Acta Psychiatr. Scand.84(6), 489–496 (1991).
   PubMed Web of Science ®Google Scholar
• Schultz SK, Miller DD, Oliver SE et al. The life course of schizophrenia: age and symptom dimensions. Schizophr. Res.23(1), 15–23 (1997).
   PubMed Web of Science ®Google Scholar
• Shtasel DL, Gur RE, Gallacher F, Heimberg C, Gur RC. Gender differences in the clinical expression of schizophrenia. Schizophr. Res.7(3), 225–231 (1992).
   PubMed Web of Science ®Google Scholar
• Andia AM, Zisook S, Heaton RK et al. Gender differences in schizophrenia. J. Nerv. Ment. Dis.183(8), 522–528 (1995).
   PubMed Web of Science ®Google Scholar
• Szymanski S, Lieberman JA, Alvir JM et al. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. Am. J. Psychiatry152(5), 698–703 (1995).
   PubMed Web of Science ®Google Scholar
• Covell NH, Weissman EM, Essock SM. Weight gain with clozapine compared to first generation antipsychotic medications. Schizophr. Bull.30(2), 229–240 (2004).
   PubMed Web of Science ®Google Scholar
• Andersen SW, Clemow DB, Corya SA. Long-term weight gain in patients treated with open-label olanzapine in combination with fluoxetine for major depressive disorder. J. Clin. Psychiatry66(11), 1468–1476 (2005).
   PubMed Web of Science ®Google Scholar
• Gregg EW, Gu Q, Cheng YJ, Narayan KM, Cowie CC. Mortality trends in men and women with diabetes, 1971 to 2000. Ann. Intern. Med.147(3), 149–155 (2007).
   PubMed Web of Science ®Google Scholar
• Regitz-Zagrosek V, Lehmkuhl E, Weickert MO. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin. Res. Cardiol.95(3), 136–147 (2006).
   PubMed Web of Science ®Google Scholar
• Cubbon RM, Rajwani A, Abbas A et al. Hyperglycaemia, in relation to sex, and mortality after acute coronary syndrome. Eur. J. Cardiovasc. Prev. Rehabil.14(5), 666–671 (2007).
   PubMedGoogle Scholar
• Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE. Diabetes mellitus and breast cancer: a retrospective population-based cohort study. Breast Cancer Res. Treat.98(3), 349–356 (2006).
   PubMed Web of Science ®Google Scholar
• Lin HC, Hsiao FH, Pfeiffer S, Hwang YT, Lee HC. An increased risk of stroke among young schizophrenia patients. Schizophr. Res.101(1–3), 234–241 (2008).
   PubMed Web of Science ®Google Scholar
• Behl C. Estrogen can protect neurons: modes of action. J. Steroid Biochem. Mol. Biol.83(1–5), 195–197 (2002).
   PubMed Web of Science ®Google Scholar
• Goff DC, Sullivan LM, McEvoy JP et al. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr. Res.80(1), 45–53 (2005).
   PubMed Web of Science ®Google Scholar
• Czlonkowska AI, Zienowicz M, Bidzinski A et al. The role of neurosteroids in the anxiolytic,antidepressive- and anticonvulsive effects of selective serotonin reuptake inhibitors. Med. Sci. Monit.9(11), RA270–RA275 (2003).
   PubMedGoogle Scholar
• Ostlund H, Keller E, Hurd YL. Estrogen receptor gene expression in relation to neuropsychiatric disorders. Ann. NY Acad. Sci.1007, 54–63 (2003).
   PubMed Web of Science ®Google Scholar
• Dluzen DE. Estrogen, testosterone, and gender differences. Endocrine27(3), 259–267 (2005).
   PubMed Web of Science ®Google Scholar
• Fink G, Sumner BE, Rosie R, Grace O, Quinn JP. Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell Mol. Neurobiol.16(3), 325–344 (1996).
   PubMed Web of Science ®Google Scholar
• Sherwin BB. Cognitive assessment for postmenopausal women and general assessment of their mental health. Psychopharmacol. Bull.34(3), 323–326 (1998).
   PubMed Web of Science ®Google Scholar
• Sherwin BB. Surgical menopause, estrogen, and cognitive function in women: what do the findings tell us? Ann. NY Acad. Sci.1052, 3–10 (2005).
   PubMed Web of Science ®Google Scholar
• Seeman MV. The role of estrogen in schizophrenia. J. Psychiatry Neurosci.21(2), 123–127 (1996).
   PubMed Web of Science ®Google Scholar
• Seeman MV. Psychopathology in women and men: focus on female hormones. Am. J. Psychiatry154(12), 1641–1647 (1997).
   PubMed Web of Science ®Google Scholar
• Grigoriadis S, Seeman MV. The role of estrogen in schizophrenia: implications for schizophrenia practice guidelines for women. Can. J. Psychiatry47(5), 437–442 (2002).
   PubMed Web of Science ®Google Scholar
• Cohen RZ, Seeman MV, Gotowiec A, Kopala L. Earlier puberty as a predictor of later onset of schizophrenia in women. Am. J. Psychiatry156(7), 1059–1064 (1999).
   PubMed Web of Science ®Google Scholar
• Chang SS, Renshaw DC. Psychosis and pregnancy. Compr. Ther.12(10), 36–41 (1986).
   PubMedGoogle Scholar
• Kendell RE, Chalmers JC, Platz C. Epidemiology of puerperal psychoses. Br. J. Psychiatry150, 662–673 (1987).
   PubMed Web of Science ®Google Scholar
• Bergemann N, Parzer P, Runnebaum B, Resch F, Mundt C. Estrogen, menstrual cycle phases, and psychopathology in women suffering from schizophrenia. Psychol. Med.37(10), 1427–1436 (2007).
   PubMed Web of Science ®Google Scholar
• Hallonquist JD, Seeman MV, Lang M, Rector NA. Variation in symptom severity over the menstrual cycle of schizophrenics. Biol. Psychiatry33(3), 207–209 (1993).
   PubMed Web of Science ®Google Scholar
• Gattaz WF, Vogel P, Riecher-Rossler A, Soddu G. Influence of the menstrual cycle phase on the therapeutic response in schizophrenia. Biol. Psychiatry36(2), 137–139 (1994).
   PubMed Web of Science ®Google Scholar
• Hendrick V, Altshuler LL, Burt VK. Course of psychiatric disorders across the menstrual cycle. Harv. Rev. Psychiatry4(4), 200–207 (1996).
   PubMed Web of Science ®Google Scholar
• Zhang-Wong JH, Seeman MV. Antipsychotic drugs, menstrual regularity and osteoporosis risk. Arch. Womens Ment. Health5(3), 93–98 (2002).
   PubMedGoogle Scholar
• Huber TJ, Borsutzky M, Schneider U, Emrich HM. Psychotic disorders and gonadal function: evidence supporting the oestrogen hypothesis. Acta Psychiatr. Scand.109(4), 269–274 (2004).
   PubMed Web of Science ®Google Scholar
• Bergemann N, Mundt C, Parzer P et al. Estrogen as an adjuvant therapy to antipsychotics does not prevent relapse in women suffering from schizophrenia: results of a placebo-controlled double-blind study. Schizophr. Res.74(2–3), 125–134 (2005).
   PubMed Web of Science ®Google Scholar
• Sanchez MG, Bourque M, Morissette M, Di Paolo T. Steroids–dopamine interactions in the pathophysiology and treatment of CNS disorders. CNS Neurosci. Ther.16(3), e43–e71 (2010).
   PubMed Web of Science ®Google Scholar
• Guest PC, Schwarz E, Krishnamurthy D et al. Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia. Psychoneuroendocrinology DOI: 10.1016/j.psyneuen.2010.12.018 (2011) (Epub ahead of print).
   PubMedGoogle Scholar
• Ferree NK, Kamat R, Cahill L. Influences of menstrual cycle position and sex hormone levels on spontaneous intrusive recollections following emotional stimuli. Conscious Cogn. DOI: 10.1016/j.concog.2011.02.003 (2011) (Epub ahead of print).
   PubMedGoogle Scholar
• Moffat SD. Effects of testosterone on cognitive and brain aging in elderly men. Ann. NY Acad. Sci.1055, 80–92 (2005).
   PubMed Web of Science ®Google Scholar
• Mendrek A. Reversal of normal cerebral sexual dimorphism in schizophrenia: evidence and speculations. Med. Hypotheses69(4), 896–902 (2007).
   PubMed Web of Science ®Google Scholar
• Kline NS, Blair J, Cooper TB et al. A controlled seven year study of endocrine and other indices in drug treated chronic schizophrenics. Acta Psychiatr. Scand. Suppl.206, 7–75 (1968).
   PubMedGoogle Scholar
• Rinieris P, Markianos M, Hatzimanolis J, Stefanis C. A psychoendocrine study in male paranoid schizophrenics with delusional ideas of homosexual content. Acta Psychiatr. Scand.72(3), 309–314 (1985).
   PubMed Web of Science ®Google Scholar
• Oades RD, Schepker R. Serum gonadal steroid hormones in young schizophrenic patients. Psychoneuroendocrinology19(4), 373–385 (1994).
   PubMed Web of Science ®Google Scholar
• Ceskova E, Prikryl R, Kasparek T. Testosterone in first-episode schizophrenia. Neuro Endocrinol. Lett.28(6), 811–814 (2007).
   PubMed Web of Science ®Google Scholar
• Akhondzadeh S, Rezaei F, Larijani B et al. Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia. Schizophr. Res.84(2–3), 405–410 (2006).
   PubMed Web of Science ®Google Scholar
• Ko YH, Jung SW, Joe SH et al. Association between serum testosterone levels and the severity of negative symptoms in male patients with chronic schizophrenia. Psychoneuroendocrinology32(4), 385–391 (2007).
   PubMed Web of Science ®Google Scholar
• Shirayama Y, Hashimoto K, Suzuki Y, Higuchi T. Correlation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophrenia. Schizophr. Res.58(1), 69–74 (2002).
   PubMed Web of Science ®Google Scholar
• van Rijn S, Aleman A, de Sonneville L et al. Neuroendocrine markers of high risk for psychosis: salivary testosterone in adolescent boys with prodromal symptoms. Psychol. Med.21, 1–8 (2011).
   Google Scholar
• Swaab DF, Garcia-Falgueras A. Sexual differentiation of the human brain in relation to gender identity and sexual orientation. Funct. Neurol.24(1), 17–28 (2009).
   PubMed Web of Science ®Google Scholar
• Arnold AP. The organizational-activational hypothesis as the foundation for a unified theory of sexual differentiation of all mammalian tissues. Horm. Behav.55(5), 570–578 (2009).
   PubMed Web of Science ®Google Scholar
• Cahill L, Gorski L, Belcher A, Huynh Q. The influence of sex versus sex-related traits on long-term memory for gist and detail from an emotional story. Conscious Cogn.13(2), 391–400 (2004).
   PubMed Web of Science ®Google Scholar
• Wood JL, Heitmiller D, Andreasen NC, Nopoulos P. Morphology of the ventral frontal cortex: relationship to femininity and social cognition. Cereb. Cortex18(3), 534–540 (2008).
   PubMed Web of Science ®Google Scholar
• Hausmann M, Schoofs D, Rosenthal HE, Jordan K. Interactive effects of sex hormones and gender stereotypes on cognitive sex differences – a psychobiosocial approach. Psychoneuroendocrinology34(3), 389–401 (2009).
   PubMed Web of Science ®Google Scholar
• Faludi G, Mirnics K. Synaptic changes in the brain of subjects with schizophrenia. Int. J. Dev. Neurosci.29(3), 305–309 (2011).
   PubMed Web of Science ®Google Scholar
• Andreasen NC, Ehrhardt JC, Swayze VW 2nd et al. Magnetic resonance imaging of the brain in schizophrenia. The pathophysiologic significance of structural abnormalities. Arch. Gen. Psychiatry47(1), 35–44 (1990).
   PubMed Web of Science ®Google Scholar
• Reite M, Sheeder J, Teale P et al. Magnetic source imaging evidence of sex differences in cerebral lateralization in schizophrenia. Arch. Gen. Psychiatry54(5), 433–440 (1997).
   PubMed Web of Science ®Google Scholar
• Gur RE, Cowell PE, Latshaw A et al. Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia. Arch. Gen. Psychiatry57(8), 761–768 (2000).
   PubMed Web of Science ®Google Scholar
• Flaum M, O’Leary DS, Swayze VW 2nd et al. Symptom dimensions and brain morphology in schizophrenia and related psychotic disorders. J. Psychiatr. Res.29(4), 261–276 (1995).
   PubMed Web of Science ®Google Scholar
• Lauriello J, Hoff A, Wieneke MH et al. Similar extent of brain dysmorphology in severely ill women and men with schizophrenia. Am. J. Psychiatry154(6), 819–825 (1997).
   PubMed Web of Science ®Google Scholar
• Schlaepfer TE, Harris GJ, Tien AY et al. Structural differences in the cerebral cortex of healthy female and male subjects: a magnetic resonance imaging study. Psychiatry Res.61(3), 129–135 (1995).
   PubMed Web of Science ®Google Scholar
• Paus T, Otaky N, Caramanos Z et al. In vivo morphometry of the intrasulcal gray matter in the human cingulate, paracingulate, and superior-rostral sulci: hemispheric asymmetries, gender differences and probability maps. J. Comp. Neurol.376(4), 664–673 (1996).
   PubMed Web of Science ®Google Scholar
• Harasty J, Double KL, Halliday GM, Kril JJ, McRitchie DA. Language-associated cortical regions are proportionally larger in the female brain. Arch. Neurol.54(2), 171–176 (1997).
   PubMed Web of Science ®Google Scholar
• Goldstein JM, Seidman LJ, Horton NJ et al. Normal sexual dimorphism of the adult human brain assessed by in vivo magnetic resonance imaging. Cereb. Cortex11(6), 490–497 (2001).
   PubMed Web of Science ®Google Scholar
• Murphy DG, DeCarli C, McIntosh AR et al. Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. Arch. Gen. Psychiatry53(7), 585–594 (1996).
   PubMed Web of Science ®Google Scholar
• Allen LS, Hines M, Shryne JE, Gorski RA. Two sexually dimorphic cell groups in the human brain. J. Neurosci.9(2), 497–506 (1989).
   PubMed Web of Science ®Google Scholar
• Agartz I, Saaf J, Wahlund LO, Wetterberg L. Quantitative estimations of cerebrospinal fluid spaces and brain regions in healthy controls using computer-assisted tissue classification of magnetic resonance images: relation to age and sex. Magn. Reson. Imaging10(2), 217–226 (1992).
   PubMed Web of Science ®Google Scholar
• Zhou JN, Hofman MA, Gooren LJ, Swaab DF. A sex difference in the human brain and its relation to transsexuality. Nature378(6552), 68–70 (1995).
   PubMed Web of Science ®Google Scholar
• Goldstein JM, Seidman LJ, O’Brien LM et al. Impact of normal sexual dimorphisms on sex differences in structural brain abnormalities in schizophrenia assessed by magnetic resonance imaging. Arch. Gen. Psychiatry59(2), 154–164 (2002).
   PubMed Web of Science ®Google Scholar
• Takahashi T, Suzuki M, Kawasaki Y et al. Perigenual cingulate gyrus volume in patients with schizophrenia: a magnetic resonance imaging study. Biol. Psychiatry53(7), 593–600 (2003).
   PubMed Web of Science ®Google Scholar
• Takahashi T, Suzuki M, Zhou SY et al. Lack of normal gender differences of the perigenual cingulate gyrus in schizophrenia spectrum disorders. A magnetic resonance imaging study. Eur. Arch. Psychiatry Clin. Neurosci.254(5), 273–280 (2004).
   PubMed Web of Science ®Google Scholar
• Gur RC, Gunning-Dixon FM, Turetsky BI, Bilker WB, Gur RE. Brain region and sex differences in age association with brain volume: a quantitative MRI study of healthy young adults. Am. J. Geriatr. Psychiatry10(1), 72–80 (2002).
   PubMed Web of Science ®Google Scholar
• Gur RE, Kohler C, Turetsky BI et al. A sexually dimorphic ratio of orbitofrontal to amygdala volume is altered in schizophrenia. Biol. Psychiatry55(5), 512–517 (2004).
   PubMed Web of Science ®Google Scholar
• Frazier JA, Hodge SM, Breeze JL et al. Diagnostic and sex effects on limbic volumes in early-onset bipolar disorder and schizophrenia. Schizophr. Bull.34(1), 37–46 (2008).
   PubMed Web of Science ®Google Scholar
• Killgore WD, Yurgelun-Todd DA. Sex differences in amygdala activation during the perception of facial affect. Neuroreport12(11), 2543–2547 (2001).
   PubMed Web of Science ®Google Scholar
• Schneider F, Habel U, Kessler C, Salloum JB, Posse S. Gender differences in regional cerebral activity during sadness. Hum. Brain Mapp.9(4), 226–238 (2000).
   PubMed Web of Science ®Google Scholar
• Canli T, Desmond JE, Zhao Z, Gabrieli JD. Sex differences in the neural basis of emotional memories. Proc. Natl Acad. Sci. USA99(16), 10789–10794 (2002).
   PubMed Web of Science ®Google Scholar
• Lee TM, Liu HL, Hoosain R et al. Gender differences in neural correlates of recognition of happy and sad faces in humans assessed by functional magnetic resonance imaging. Neurosci. Lett.333(1), 13–16 (2002).
   PubMed Web of Science ®Google Scholar
• Lee TM, Liu HL, Chan CC, Fang SY, Gao JH. Neural activities associated with emotion recognition observed in men and women. Mol. Psychiatry10(5), 450–455 (2005).
   PubMed Web of Science ®Google Scholar
• Wrase J, Klein S, Gruesser SM et al. Gender differences in the processing of standardized emotional visual stimuli in humans: a functional magnetic resonance imaging study. Neurosci. Lett.348(1), 41–45 (2003).
   PubMed Web of Science ®Google Scholar
• Fischer AH, Rodriguez Mosquera PM, van Vianen AE, Manstead AS. Gender and culture differences in emotion. Emotion4(1), 87–94 (2004).
   PubMed Web of Science ®Google Scholar
• Hofer A, Siedentopf CM, Ischebeck A et al. Gender differences in regional cerebral activity during the perception of emotion: a functional MRI study. Neuroimage32(2), 854–862 (2006).
   PubMed Web of Science ®Google Scholar
• Thomsen T, Hugdahl K, Ersland L et al. Functional magnetic resonance imaging (fMRI) study of sex differences in a mental rotation task. Med. Sci. Monit.6(6), 1186–1196 (2000).
   PubMedGoogle Scholar
• Jordan K, Wustenberg T, Heinze HJ, Peters M, Jancke L. Women and men exhibit different cortical activation patterns during mental rotation tasks. Neuropsychologia40(13), 2397–2408 (2002).
   PubMed Web of Science ®Google Scholar
• Weiss E, Siedentopf CM, Hofer A et al. Sex differences in brain activation pattern during a visuospatial cognitive task: a functional magnetic resonance imaging study in healthy volunteers. Neurosci. Lett.344(3), 169–172 (2003).
   PubMed Web of Science ®Google Scholar
• Hugdahl K, Thomsen T, Ersland L. Sex differences in visuo–spatial processing: an fMRI study of mental rotation. Neuropsychologia44(9), 1575–1583 (2006).
   PubMed Web of Science ®Google Scholar
• Crespo-Facorro B, Paradiso S, Andreasen NC et al. Neural mechanisms of anhedonia in schizophrenia: a PET study of response to unpleasant and pleasant odors. JAMA286(4), 427–435 (2001).
   PubMed Web of Science ®Google Scholar
• Paradiso S, Andreasen NC, Crespo-Facorro B et al. Emotions in unmedicated patients with schizophrenia during evaluation with positron emission tomography. Am. J. Psychiatry160(10), 1775–1783 (2003).
   PubMed Web of Science ®Google Scholar
• Guillem F, Mograss M. Gender differences in memory processing: evidence from event-related potentials to faces. Brain Cogn.57(1), 84–92 (2005).
   PubMed Web of Science ®Google Scholar
• Guillem F, Mendrek A, Lavoie ME, Pampoulova T, Stip E. Sex differences in memory processing in schizophrenia: an event-related potential (ERP) study. Prog. Neuropsychopharmacol. Biol. Psychiatry33(1), 1–10 (2009).
   PubMed Web of Science ®Google Scholar
• Mendrek A, Mancini-Marie A, Fahim C, Stip E. Sex differences in the cerebral function associated with processing of aversive stimuli by schizophrenia patients. Aust. NZ J. Psychiatry41(2), 136–141 (2007).
   PubMed Web of Science ®Google Scholar
• Mendrek A, Mancini-Marïe A, Jiménez J et al. Sex differences in the processing of positive and negative affect in schizophrenia: an fMRI and ERP study. Schizophrenia Bull.35(S1), 164 (2009).
   Google Scholar
• Jiménez JA, Mancini-Marïe A, Lakis N, Rinaldi M, Mendrek A. Disturbed sexual dimorphism of brain activation during mental rotation in schizophrenia. Schizophr. Res.122(1–3), 53–62 (2010).
   PubMed Web of Science ®Google Scholar
• Kulkarni J, de Castella A, Smith D et al. A clinical trial of the effects of estrogen in acutely psychotic women. Schizophr. Res.20(3), 247–252 (1996).
   PubMed Web of Science ®Google Scholar
• Kulkarni J, Riedel A, de Castella AR et al. Estrogen – a potential treatment for schizophrenia. Schizophr. Res.48(1), 137–144 (2001).
   PubMed Web of Science ®Google Scholar
• Kulkarni J, de Castella A, Fitzgerald PB et al. Estrogen in severe mental illness: a potential new treatment approach. Arch. Gen. Psychiatry65(8), 955–960 (2008).
   PubMed Web of Science ®Google Scholar
• Akhondzadeh S, Nejatisafa AA, Amini H et al. Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial. Prog. Neuropsychopharmacol. Biol. Psychiatry27(6), 1007–1012 (2003).
   PubMed Web of Science ®Google Scholar
• Kulkarni J, de Castella A, Headey B et al. Estrogens and men with schizophrenia: is there a case for adjunctive therapy? Schizophr. Res.125(2–3), 278–283 (2011).
   PubMed Web of Science ®Google Scholar
• Ko YH, Lew YM, Jung SW et al. Short-term testosterone augmentation in male schizophrenics: a randomized, double-blind, placebo-controlled trial. J. Clin. Psychopharmacol.28(4), 375–383 (2008).
   PubMed Web of Science ®Google Scholar
• Elias A, Kumar A. Testosterone for schizophrenia. Cochrane Database Syst. Rev.3, CD006197 (2007).
   Google Scholar
• Cahill L. Sex influences on brain and emotional memory: the burden of proof has shifted. Prog. Brain Res.186, 29–40 (2010).
   PubMed Web of Science ®Google Scholar
• Dhandapani KM, Brann DW. Protective effects of estrogen and selective estrogen receptor modulators in the brain. Biol. Reprod.67(5), 1379–1385 (2002).
   PubMed Web of Science ®Google Scholar
• Ciriza I, Carrero P, Azcoitia I, Lundeen SG, Garcia-Segura LM. Selective estrogen receptor modulators protect hippocampal neurons from kainic acid excitotoxicity: differences with the effect of estradiol. J. Neurobiol.61(2), 209–221 (2004).
   PubMedGoogle Scholar
• Zhao L, O’Neill K, Brinton RD. Estrogenic agonist activity of ICI 182,780 (Faslodex) in hippocampal neurons: implications for basic science understanding of estrogen signaling and development of estrogen modulators with a dual therapeutic profile. J. Pharmacol. Exp. Ther.319(3), 1124–1132 (2006).
   PubMed Web of Science ®Google Scholar
• Cyr M, Calon F, Morissette M et al. Drugs with estrogen-like potency and brain activity: potential therapeutic application for the CNS. Curr. Pharm. Des.6(12), 1287–1312 (2000).
   PubMed Web of Science ®Google Scholar
• Kulkarni J, Gurvich C, Lee SJ et al. Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia. Psychoneuroendocrinology35(8), 1142–1147 (2010).
   PubMed Web of Science ®Google Scholar
• Callier S, Morissette M, Grandbois M, Pelaprat D, Di Paolo T. Neuroprotective properties of 17β-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice. Synapse41(2), 131–138 (2001).
   PubMed Web of Science ®Google Scholar
• Wright DW, Kellermann AL, Hertzberg VS et al. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann. Emerg. Med.49(4), 391–402, e391–e392 (2007).
   PubMed Web of Science ®Google Scholar
• Xiao G, Wei J, Yan W, Wang W, Lu Z. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit. Care12(2), R61 (2008).
   PubMed Web of Science ®Google Scholar
• Strous RD. Dehydroepiandrosterone (DHEA) augmentation in the management of schizophrenia symptomatology. Essent. Psychopharmacol.6(3), 141–147 (2005).
   PubMedGoogle Scholar
• Ritsner MS. Pregnenolone, dehydroepiandrosterone, and schizophrenia: alterations and clinical trials. CNS Neurosci. Ther.16(1), 32–44 (2010).
   PubMed Web of Science ®Google Scholar
• Strous RD, Maayan R, Lapidus R et al. Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Arch. Gen. Psychiatry60(2), 133–141 (2003).
   PubMed Web of Science ®Google Scholar
• Ritsner MS, Gibel A, Shleifer T et al. Pregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder: an 8-week, double-blind, randomized, controlled, 2-center, parallel-group trial. J. Clin. Psychiatry71(10), 1351–1362 (2010).
   PubMed Web of Science ®Google Scholar
• Ritsner MS, Gibel A, Ratner Y, Tsinovoy G, Strous RD. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial. J. Clin. Psychopharmacol.26(5), 495–499 (2006).
   PubMed Web of Science ®Google Scholar
• Strous RD, Stryjer R, Maayan R et al. Analysis of clinical symptomatology, extrapyramidal symptoms and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in olanzapine treated schizophrenia patients: a randomized, double-blind placebo controlled trial. Psychoneuroendocrinology32(2), 96–105 (2007).
   PubMed Web of Science ®Google Scholar